GRAIL, Inc. (GRAL) stock analysis
In our weekly check, GRAIL, Inc. is graded D (A to F). Of 20 checks on debt, profit, cash flow and trend: 8 pass, warnings: 2, red flags: 10.
About GRAIL, Inc.
GRAIL, Inc. is a Healthcare company (Medical - Diagnostics & Research) based in the United States, listed on NASDAQ as GRAL.
What our checks show for GRAL
Red flags
- The company has net debt but no positive operating earnings (EBITDA) to service it from (debt/equity 0.03).
- Weak EPS forecast
- Earnings per share fell 62.1% a year over the last 3 years.
- The company is losing money: the net margin is -244%.
- Free cash flow is negative (-180% of revenue): the business spends more cash than it brings in.
- The price swings a lot: 134% annual volatility. Expect large ups and downs.
- The stock has fallen as much as 63% from a peak. Would you have held through that?
- Beta 3.25: the stock usually moves more than the market, both up and down.
- Return on capital (ROCE) is zero or negative: the business does not earn on the money put into it.
- Free cash flow is negative, so no cash is left over to cover pay in shares.
Warning signs
- Operating cash flow is negative while the company reports a profit: the profit does not arrive as cash.
- The share count grew by 18.4% in 2 years: each shareholder owns a smaller slice.
Strengths
- The net margin rose by 8296 points over 5 years, to -244%.
- Analysts expect revenue to grow about 25.1% a year over the next years.
- Analysts expect the net margin to improve by 113 points from today's -244%.
- Revenue grew 44.2% a year over the last 3 years.
Similar companies
BLLN · SHC · RDNT · CDNA · QGEN · NEO
Questions
What grade does GRAIL, Inc. (GRAL) have?
In our weekly check, GRAIL, Inc. is graded D (A to F). Of 20 checks on debt, profit, cash flow and trend: 8 pass, warnings: 2, red flags: 10. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of GRAL stock?
This week's biggest flags for GRAIL, Inc.: High debt, Weak EPS forecast, Weak EPS growth. In total 12 of 20 checks show a warning or a red flag.
What does GRAIL, Inc. do?
GRAIL, Inc. is a Healthcare company (Medical - Diagnostics & Research) based in the United States, listed on NASDAQ as GRAL.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis